Boston Scientific and the Mayo Clinic announced on March 16 that they would continue to share intellectual property to develop medical devices that address unmet clinical needs in fields such as interventional cardiology, heart rhythm management, endoscopy, neuromodulation, urology and pelvic health.
Currently, there are several clinical programs underway, including a Mayo Clinic study evaluating a guide catheter for catheter-based aortic valve replacement. Another Mayo Clinic study is examining the use of Boston Scientific’s Precision Spectra Spinal Cord Stimulator System when patients with heart failure exercise.
Mayo Clinic Ventures is managing the collaboration between the companies. In 2015, the Mayo Clinic cared for 1.3 million patients.